Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
The value of local infiltration of bupivicaine during Perforate Invaginate (PIN) stripping of the long saphenous vein: a randomised, double-blind, placebo-controlled trial.
ISRCTN ISRCTN58431114
ClinicalTrials.gov identifier
Public title The value of local infiltration of bupivicaine during Perforate Invaginate (PIN) stripping of the long saphenous vein: a randomised, double-blind, placebo-controlled trial.
Scientific title
Acronym N/A
Serial number at source N0274135608
Study hypothesis To determine whether infiltration of the strip tract with local anaesthetic during Perforate Invaginate (PIN) stripping produces a significant reduction in post-operative pain
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised double-blind placebo-controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Signs and Symptoms: Post-operative pain
Participants - inclusion criteria Patients with sapheno-femoral incompetence documented on duplex scanning who are undergoing elective unilateral sapheno-femoral disconnection and PIN stripping of the long saphenous vein with multiple avulsions.
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 04/07/2003
Anticipated end date 31/03/2005
Status of trial Completed
Patient information material
Target number of participants Added as of 15/04/2008: 27
Interventions Infiltration of bupivicaine vs placebo
Primary outcome measure(s) Numerical pain scores at 1, 6 and 24 hours post-operatively. Analgesic consumption in the first 24 hours post-operatively.
Secondary outcome measure(s) Not provided at time of registration
Sources of funding West Suffolk Hospitals NHS Trust (UK)
Trial website
Publications 2007 results in http://www.ncbi.nlm.nih.gov/pubmed/18269072
Contact name Dr  S  Walsh
  Address West Suffolk Hospitals NHS Trust
Hardwick Lane
  City/town Bury St Edmunds
  Zip/Postcode IP33 2QZ
  Country United Kingdom
Sponsor Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)
  Address The Department of Health,
Richmond House,
79 Whitehall
  City/town London
  Zip/Postcode SW1A 2NL
  Country United Kingdom
  Tel +44 (0)20 7307 2622
  Email dhmail@doh.gsi.org.uk
  Sponsor website: http://www.dh.gov.uk/Home/fs/en
Date applied 30/09/2004
Last edited 02/07/2009
Date ISRCTN assigned 30/09/2004
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central